Načítá se...
Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term
BACKGROUND: To present a comprehensive approach for the management of patients with neovascular glaucoma (NVG) aiming to preserve visual function and complement pan-retinal photocoagulation (PRP) by anti-vascular endothelial growth factor (anti-VEGF) treatment and anti-glaucoma surgery. METHODS: Thi...
Uloženo v:
| Vydáno v: | BMC Ophthalmol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5006321/ https://ncbi.nlm.nih.gov/pubmed/27576739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-016-0327-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|